That journey began with the work of spine surgeon and clinician-scientist Dr. Ashish Diwan. In 2008, Dr. Diwan co-authored a study connecting GDF6 mutations with a rare condition that affects spinal development. The research also demonstrated GDF6 expression in the adult intervertebral disc. Cartago is now translating these insights into a potential regenerative treatment for people living with chronic low back pain caused by disc degeneration.
Meet the teamAbout
About Cartago
Cartago was founded on a simple but ambitious idea: if we can understand how spinal discs develop and repair, we may be able to change the course of disc degeneration.
Our story
Our team
Meet the team
Surgeons, scientists and drug-development specialists, working with UNSW and a US regulatory group.
Clinical Affairs
UNSW, CRU
Manufacturing & Regulatory Affairs
Biologics Consulting Group, USA
Research & Development
UNSW
